Pipeline Portfolio company Portfolio company Artax Biopharma COMPOUND COMPOUND AX-158 INDICATION INDICATION Psoriasis Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company Arthex COMPOUND COMPOUND ATX-01 INDICATION INDICATION Myotonic Dystrophy Type 1 Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company Breye COMPOUND COMPOUND Danegaptide INDICATION INDICATION Diabetic Retinopathy Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company Breye COMPOUND COMPOUND Undisclosed INDICATION INDICATION Age-related Macular Degeneration Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company Teitur COMPOUND COMPOUND TT-P34 INDICATION INDICATION Huntington’s Disease Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company Aboleris COMPOUND COMPOUND ABIS-45RC INDICATION INDICATION Rheumatoid Arthritis Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company Theolytics COMPOUND COMPOUND THEO-260 INDICATION INDICATION Ovarian Cancer Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company NephroDI COMPOUND COMPOUND NDI-5001 INDICATION INDICATION Congenital Nephrogenic Diabetes Insipidus Progress Pre-clinical PHASE I PHASE II PHASE III Portfolio company Portfolio company VarmX COMPOUND COMPOUND VMX-C001 INDICATION INDICATION Reversal of Factor Xa DOAC blood thinners Progress Pre-clinical PHASE I PHASE II PHASE III